Usa state Massachusets hospital virus covid-19 vaccine Usa state Massachusets

Novartis’ AveXis agrees to manufacture US researcher Covid-19 vaccine

Reading now: 841
www.pharmaceutical-technology.com

Novartis unit AveXis has entered a manufacturing agreement with researchers at Massachusetts Eye and Ear and Massachusetts General Hospital in the US to produce a genetic vaccine against Covid-19, AAVCOVID.

AveXis will leverage its gene therapy manufacturing expertise to produce and scale the AAVCOVID vaccine candidate, which uses adeno-associated virus (AAV) vector, for clinical trials.

The company will start producing the vaccine this month. Currently, the vaccine is being tested for safety and efficacy in preclinical studies at various academic medical institutions, including Massachusetts Eye and Ear.

For manufacturing the vaccine, AveXis will use its AAV technology designed for the treatment of rare, life-threatening neurological

Read more on pharmaceutical-technology.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA